SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001745020-23-000037
Filing Date
2023-06-13
Accepted
2023-06-13 17:29:34
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686691764.html 4  
1 FORM 4 wk-form4_1686691764.xml 4 6564
  Complete submission text file 0001745020-23-000037.txt   7945
Mailing Address C/O AMICUS THERAPEUTICS, INC. 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
HAYDEN DONALD J JR (Reporting) CIK: 0001202285 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 231012282

Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations